Jing Wang
机构:Shihezi University, Novartis (Switzerland), Fujian Medical University, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Beijing Technology and Business University, Shanxi University, Capital Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Xinjiang Production and Construction Corps, Academy of Military Medical Sciences, Soochow University, Beijing VDJBio (China), Henan University Huaihe Hospital and Huaihe Clinical Institute, National Cancer Center, First Affiliated Hospital of Guangzhou Medical University, Novartis (United States), National Clinical Research, Songjiang District Central Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University, Hanzhong People's Hospital, Cancer Hospital of Chinese Academy of Medical Sciences, Guizhou Provincial People's Hospital, Beijing Shijitan Hospital, Tongji Hospital, Qilu Hospital of Shandong University, Fu Wai Hospital, First Affiliated Hospital of Jinan University, Huazhong University of Science and Technology, Southern Medical University, Zhejiang University, Chongqing Medical University, Guangzhou Medical University · ORCID:0000-0002-3224-3993
发表论文 383 篇 · 总被引 6767 次 · h-index 41
代表论文
- Combating cancer immunotherapy resistance: a nano‐medicine perspective (2025 · 癌症:英文版 · 被引 13)
- ACE2 Alleviates Microglia Neuroinflammation by RANK-RANKL-OPG Axis in Parkinson’s Disease (2025 · Inflammation · 被引 11)
- Tall Cell Carcinoma with Reversed Polarity of the breast: Clinicopathological insights, molecular profile, and future therapeutic directions (2025 · The Breast · 被引 5)
- Metabolomic profiling reveals distinct metabolic patterns and a potential circulating biomarker in pre-COPD (2025 · Chinese Medical Journal · 被引 5)
- Short-term clinical efficacy of unilateral biportal endoscopic unilateral laminectomy for bilateral decompression for lumbar epidural lipomatosis: an observational study (2025 · BMC Musculoskeletal Disorders · 被引 4)
- Rice protein-derived hypoglycemic peptides IQP,VEP and IPQ alleviate obesity-related metabolic disorders in high-fat diet (HFD)-induced C57BL/6J mice through activation of AMPK and modulation of gut microbiota and related metabolites (2025 · Food Bioscience · 被引 4)